Journey Medical Corp (DERM): Next-Year EPS Estimate 1496.15%
As of 2026-06-04, Journey Medical Corp (DERM) has a next-year EPS growth estimate of 1496.15%.
On 2026-05-17, analyst consensus for DERM's next-year EPS growth shifted from 1289.66% to 1496.15% — a positive change of 206.49 percentage points. The revised estimate has been sustained across 15 subsequent trading sessions. Current-year growth is projected at 113.83%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 1496.15%
- EPS growth this year
- 113.83%
- EPS next quarter (est)
- -$0.02
- Last price
- $6.22
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 1496.15% | 113.83% | -$0.02 | $6.22 |
| 2026-06-03 | 1496.15% | 113.83% | -$0.02 | $6.06 |
| 2026-06-02 | 1496.15% | 113.83% | -$0.02 | $6.02 |
| 2026-06-01 | 1496.15% | 113.83% | -$0.02 | $6.09 |
| 2026-05-31 | 1496.15% | 113.83% | -$0.02 | $6.31 |
| 2026-05-28 | 1496.15% | 113.83% | -$0.02 | $6.20 |
| 2026-05-27 | 1496.15% | 113.83% | -$0.02 | $5.99 |
| 2026-05-26 | 1496.15% | 113.83% | -$0.02 | $6.12 |
| 2026-05-25 | 1496.15% | 113.83% | -$0.02 | $5.96 |
| 2026-05-24 | 1496.15% | 113.83% | -$0.02 | $5.96 |
| 2026-05-21 | 1496.15% | 113.83% | -$0.02 | $6.21 |
| 2026-05-20 | 1496.15% | 113.83% | -$0.02 | $6.17 |
| 2026-05-19 | 1496.15% | 113.83% | -$0.02 | $6.15 |
| 2026-05-18 | 1496.15% | 113.83% | -$0.02 | $6.25 |
| 2026-05-17 | 1496.15% | 113.83% | -$0.02 | $6.33 |
| 2026-05-14 | 1289.66% | 115.43% | -$0.03 | $6.35 |
| 2026-05-13 | 1303.45% | 115.43% | -$0.09 | $5.22 |
| 2026-05-12 | 1303.45% | 115.43% | -$0.09 | $5.01 |
| 2026-05-11 | 1303.45% | 115.43% | -$0.09 | $5.00 |
| 2026-05-10 | 1303.45% | 115.43% | -$0.09 | $5.07 |
| 2026-05-07 | 1303.45% | 115.43% | -$0.09 | $5.00 |
| 2026-05-06 | 1303.45% | 115.43% | -$0.09 | $5.21 |
| 2026-05-05 | 1303.45% | 115.43% | -$0.09 | $5.18 |
| 2026-05-04 | 1303.45% | 115.43% | -$0.09 | $5.12 |
| 2026-05-03 | 1303.45% | 115.43% | -$0.09 | $5.19 |
| 2026-04-30 | 1303.45% | 115.43% | -$0.09 | $5.15 |
| 2026-04-29 | 1303.45% | 115.43% | -$0.09 | $5.00 |
| 2026-04-28 | 1303.45% | 115.43% | -$0.09 | $5.26 |
| 2026-04-27 | 1303.45% | 115.43% | -$0.09 | $5.26 |
| 2026-04-26 | 1303.45% | 115.43% | -$0.09 | $5.15 |
Recent News
- Journey Medical Corporation Q4 2025 Earnings Call SummaryMoby
- Journey Medical Corp (DERM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...GuruFocus.com
- Journey Medical Corp (DERM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...GuruFocus.com
- Journey Medical Corp (DERM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...GuruFocus.com
- Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate HighlightsGlobeNewswire
- Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate HighlightsGlobeNewswire
- Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate HighlightsGlobeNewswire
- Journey Medical Corp (DERM) Q4 2025: Everything You Need To Know Ahead Of EarningsGuruFocus.com
- Journey Medical Corp (DERM) Q4 2025: Everything You Need To Know Ahead Of EarningsGuruFocus.com
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Journey Medical Corp's next-year EPS growth estimate?▾
As of 2026-06-04, Journey Medical Corp (DERM) has a next-year EPS growth estimate of 1496.15%, based on analyst consensus.
When was the latest EPS estimate revision for DERM?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 1289.66% to 1496.15%.
What sector and industry does Journey Medical Corp belong to?▾
Journey Medical Corp operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. DERM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Journey Medical Corp (DERM) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports